These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Azotemic renal osteodystrophy. Baker J; Anderson KC; Ross G Mo Med; 1966 Oct; 63(10):807-10. PubMed ID: 5976677 [No Abstract] [Full Text] [Related]
5. [Disorders of calcium metabolism in kidney failure]. Ritz E; Krempien B; Andrassy K Med Klin; 1972 Sep; 67(36):1129-32. PubMed ID: 4561354 [No Abstract] [Full Text] [Related]
6. [Current problems of azotemic bone diseases]. Schaefer K; Opitz A Dtsch Med Wochenschr; 1970 Jan; 95(2):84-8. PubMed ID: 4902985 [No Abstract] [Full Text] [Related]
7. The relationship between disturbed metabolism of vitamin D and bone disease in chronic renal failure. Kanis JA; Russell RG; Taylor CM; Cundy T; Andrade A; Heynen G Proc Eur Dial Transplant Assoc; 1979; 16():630-6. PubMed ID: 398524 [TBL] [Abstract][Full Text] [Related]
9. Factors affecting calcium metabolism in disorders of the kidney. Favus MJ Ann Clin Lab Sci; 1981; 11(4):327-32. PubMed ID: 7023346 [TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]